Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fever | 3 | 2022 | 309 | 1.210 |
Why?
|
| Penicillin G Benzathine | 1 | 2025 | 20 | 0.960 |
Why?
|
| Syphilis, Congenital | 1 | 2025 | 30 | 0.940 |
Why?
|
| Education, Special | 1 | 2024 | 12 | 0.930 |
Why?
|
| Capsid | 4 | 2014 | 147 | 0.870 |
Why?
|
| Herpesvirus 1, Human | 3 | 2014 | 34 | 0.870 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 228 | 0.790 |
Why?
|
| Cryoelectron Microscopy | 8 | 2015 | 239 | 0.640 |
Why?
|
| Knee | 1 | 2019 | 21 | 0.640 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2019 | 24 | 0.640 |
Why?
|
| Rickettsia typhi | 1 | 2019 | 12 | 0.630 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2019 | 28 | 0.610 |
Why?
|
| Meningitis | 1 | 2019 | 101 | 0.610 |
Why?
|
| Headache | 1 | 2019 | 111 | 0.600 |
Why?
|
| Edema | 1 | 2019 | 142 | 0.590 |
Why?
|
| Anti-Bacterial Agents | 2 | 2025 | 2519 | 0.490 |
Why?
|
| Molecular Biology | 1 | 2014 | 80 | 0.420 |
Why?
|
| Capsid Proteins | 1 | 2014 | 194 | 0.400 |
Why?
|
| Exanthema | 2 | 2022 | 71 | 0.320 |
Why?
|
| Injections, Intramuscular | 1 | 2025 | 198 | 0.230 |
Why?
|
| Eustachian Tube | 1 | 2024 | 5 | 0.230 |
Why?
|
| Dilatation | 1 | 2024 | 71 | 0.220 |
Why?
|
| International Classification of Diseases | 1 | 2024 | 100 | 0.220 |
Why?
|
| Infant, Newborn | 2 | 2025 | 8591 | 0.190 |
Why?
|
| Eosinophilia | 1 | 2022 | 106 | 0.180 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2014 | 621 | 0.180 |
Why?
|
| Hypersensitivity | 1 | 2022 | 197 | 0.170 |
Why?
|
| Mycobacterium avium Complex | 1 | 2019 | 19 | 0.160 |
Why?
|
| Photophobia | 1 | 2019 | 9 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2025 | 17488 | 0.160 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 214 | 0.150 |
Why?
|
| Bacteriophages | 3 | 2013 | 84 | 0.140 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2022 | 485 | 0.140 |
Why?
|
| Male | 5 | 2025 | 65902 | 0.140 |
Why?
|
| Humans | 14 | 2025 | 133937 | 0.130 |
Why?
|
| Tomography, X-Ray | 1 | 2016 | 3 | 0.130 |
Why?
|
| Electron Microscope Tomography | 2 | 2013 | 21 | 0.130 |
Why?
|
| Child | 5 | 2024 | 25739 | 0.130 |
Why?
|
| Child, Preschool | 2 | 2024 | 14800 | 0.130 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 79 | 0.130 |
Why?
|
| Erythrocytes | 1 | 2016 | 236 | 0.120 |
Why?
|
| Telemedicine | 1 | 2022 | 500 | 0.120 |
Why?
|
| Microtubules | 1 | 2015 | 131 | 0.120 |
Why?
|
| DNA Packaging | 1 | 2014 | 4 | 0.110 |
Why?
|
| Quality of Life | 1 | 2024 | 2143 | 0.110 |
Why?
|
| Synechococcus | 1 | 2013 | 4 | 0.110 |
Why?
|
| Virus Assembly | 1 | 2013 | 47 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1977 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2025 | 13013 | 0.100 |
Why?
|
| Blood Platelets | 1 | 2015 | 341 | 0.100 |
Why?
|
| Virus Internalization | 1 | 2012 | 60 | 0.100 |
Why?
|
| Anemia, Sickle Cell | 1 | 2016 | 341 | 0.100 |
Why?
|
| Virion | 1 | 2012 | 151 | 0.090 |
Why?
|
| Tomography | 1 | 2012 | 41 | 0.090 |
Why?
|
| Female | 5 | 2025 | 71682 | 0.090 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 464 | 0.090 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2010 | 18 | 0.090 |
Why?
|
| Viruses | 1 | 2012 | 125 | 0.090 |
Why?
|
| Mitochondria | 1 | 2015 | 746 | 0.080 |
Why?
|
| Adolescent | 2 | 2024 | 20534 | 0.080 |
Why?
|
| Infant | 1 | 2024 | 13161 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2010 | 122 | 0.080 |
Why?
|
| Fibrinolytic Agents | 1 | 2010 | 204 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1720 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 1438 | 0.060 |
Why?
|
| Research Design | 1 | 2010 | 746 | 0.060 |
Why?
|
| Acoustic Impedance Tests | 1 | 2024 | 7 | 0.060 |
Why?
|
| Ear Diseases | 1 | 2024 | 21 | 0.060 |
Why?
|
| Algorithms | 1 | 2010 | 1736 | 0.050 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2022 | 4 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2022 | 260 | 0.050 |
Why?
|
| Pancytopenia | 1 | 2022 | 42 | 0.050 |
Why?
|
| Lymphadenopathy | 1 | 2022 | 31 | 0.050 |
Why?
|
| Eosinophils | 1 | 2022 | 128 | 0.050 |
Why?
|
| Stroke | 1 | 2010 | 1065 | 0.050 |
Why?
|
| Symptom Assessment | 1 | 2022 | 108 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 198 | 0.040 |
Why?
|
| Animals | 4 | 2016 | 36387 | 0.040 |
Why?
|
| Cell Surface Extensions | 1 | 2016 | 7 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2242 | 0.030 |
Why?
|
| Aquatic Organisms | 1 | 2013 | 9 | 0.030 |
Why?
|
| Cricetinae | 1 | 2012 | 398 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2024 | 3227 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 611 | 0.020 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2010 | 12 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2012 | 360 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 870 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 240 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 396 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1132 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 1532 | 0.020 |
Why?
|
| Mice | 1 | 2016 | 18909 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 7212 | 0.010 |
Why?
|
| United States | 1 | 2010 | 11687 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 21746 | 0.010 |
Why?
|
| Middle Aged | 1 | 2010 | 29409 | 0.000 |
Why?
|